Health-related quality of life in pain-free or mildly symptomatic patients with metastatic hormone-resistant prostate cancer following treatment with the specific endothelin A receptor antagonist zibotentan (ZD4054)
2010 ◽
Vol 137
(1)
◽
pp. 99-113
◽
2009 ◽
Vol 8
(4)
◽
pp. 133
◽
2007 ◽
Vol 177
(4S)
◽
pp. 7-7
◽
Keyword(s):
2004 ◽
Vol 171
(4S)
◽
pp. 42-42
◽
2003 ◽
Vol 57
(2)
◽
pp. S437
2010 ◽
Vol 107
(8)
◽
pp. 1223-1231
◽
Keyword(s):